These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1602187)
1. Immunology of a burnt-out lepromatous leprosy patient. Baliña LN; Jotimliansky L; Sasiain MC; Minnucci F; Kien MC; Chouela E Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):102-4. PubMed ID: 1602187 [No Abstract] [Full Text] [Related]
2. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients. Ohman R; Walford C; Converse P; Ridell M Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990 [No Abstract] [Full Text] [Related]
3. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Rada EM; Aranzazu N; Convit J Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162 [No Abstract] [Full Text] [Related]
4. Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL). Rada EM; Zambrano EA; Aranzazu N; Convit J Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):222-5. PubMed ID: 16830648 [No Abstract] [Full Text] [Related]
5. A 28-kDa protein from Mycobacterium leprae is a target of the human antibody response in lepromatous leprosy. Cherayil BJ; Young RA J Immunol; 1988 Dec; 141(12):4370-5. PubMed ID: 3058804 [TBL] [Abstract][Full Text] [Related]
6. Recognition of Mycobacterium leprae antigens with antibodies present in sera from patients with lepromatous leprosy. Islas-Rodríguez AE; Guillén-Vargas CM; Fafutis-Morris M; Alfaro-Bustamante F; Morales-Ortíz R; Gonzalez-Mendoza A; Estrada-Parra I Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):245-9. PubMed ID: 7690388 [TBL] [Abstract][Full Text] [Related]
7. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients. Corbeau P; Desforges S; Bach MA Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800 [No Abstract] [Full Text] [Related]
8. Immunological profile of treated lepromatous leprosy patients. Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763 [TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses of healthy and Mycobacterium leprae-inoculated armadillos (Dasypus novemcinctus). Rivero-Nava L; Quesada-Pascual F; Estrada-Garcia I; Estrada-Parra S; Santos-Argumedo L Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):485-7. PubMed ID: 10347570 [No Abstract] [Full Text] [Related]
10. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders. Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Godal T; Myklestad B; Samuel DR; Myrvang B Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to phenolic glycolipid-I and sulfatide-I in leprosy and tuberculosis. Luna-Herrera J; Arce-Paredes P; Rojas-Espinosa O Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):327-9. PubMed ID: 8862271 [No Abstract] [Full Text] [Related]
13. Immunology of leprosy. Britton WJ Trans R Soc Trop Med Hyg; 1993; 87(5):508-14. PubMed ID: 8266398 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination. Gangal SG; Chiplunkar SV; Shinde SR; Samson PD; Deo MG Trop Med Parasitol; 1990 Sep; 41(3):314-6. PubMed ID: 1701562 [No Abstract] [Full Text] [Related]
16. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings]. Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098 [TBL] [Abstract][Full Text] [Related]
17. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Roche PW; Britton WJ; Failbus SS; Williams D; Pradhan HM; Theuvenet WJ Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):480-90. PubMed ID: 2205683 [TBL] [Abstract][Full Text] [Related]
18. Detection of antibodies to 35 kD determinant of M. leprae in urine and serum of leprosy patients. Patil S; Dwivedi P; Kiran K; Singh K; Sengupta U Acta Leprol; 1990; 7(2):139-43. PubMed ID: 1699385 [TBL] [Abstract][Full Text] [Related]